Health care stocks were lower Thursday afternoon, with the NYSE Health Care Index down 0.5% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.7%.
The iShares Biotechnology ETF (IBB) fell 0.8%.
In corporate news, Bausch + Lomb (BLCO) said a go-private deal with a third-party buyer won't materialize at this time. The deal was one of the options being explored to complete a full separation from Bausch Health (BHC), it said. Bausch + Lomb shares fell 8.5%, and Bausch Health was down 8.3%.
Prestige Consumer Healthcare (PBH) shares jumped 13% after its fiscal Q3 adjusted earnings and revenue came in ahead of analysts' estimates.
Globus Medical (GMED) and Nevro (NVRO) said Thursday that Globus has agreed to buy Nevro in all-cash deal valued at $250 million. Globus shares fell 4% and Nevro surged 14%.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。